Both silencing MAT2A and SLC7A6 could decreased the cell proliferation rate of BCa cells (Fig. S10D), while MAT2A silencing significantly contributes to the cisplatin sensitivity than SLC7A6 in cisplatin resistant cancer cells (Fig. S10E). The gene discussed is SLC7A6; the disease is cancer.